Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hyper IgM syndromes.

A Virginia Gulino1, Luigi D Notarangelo

  • 1Department of Pediatrics, University of Brescia, Italy.

Current Opinion in Rheumatology
|June 24, 2003
PubMed
Summary
This summary is machine-generated.

Primary immune deficiencies, known as hyper-IgM syndromes, reveal new genes and molecular events crucial for B-cell differentiation and antibody production. Studying these conditions advances understanding of immune responses and related diseases.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Human LY9 governs CD4<sup>+</sup> T cell IFN-γ immunity to <i>Mycobacterium tuberculosis</i>.

Science immunology·2025
Same author

A multimorphic variant in ThPOK causes an inborn error of immunity with T cell defects and fibrosis.

The Journal of experimental medicine·2025
Same author

Immunopathological and microbial signatures of inflammatory bowel disease in partial RAG deficiency.

The Journal of experimental medicine·2025
Same author

Prior SARS-CoV-2 infection affects adaptive immune responses to Omicron BA.4/BA.5 mRNA booster.

The Journal of allergy and clinical immunology·2025
Same author

A large-scale database of T-cell receptor beta sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.

Frontiers in immunology·2025
Same author

The ClinGen Severe Combined Immunodeficiency Disease Variant Curation Expert Panel: Specifications for classification of variants in <i>ADA</i> , <i>DCLRE1C</i> , <i>IL2RG</i> , <i>IL7R</i> , <i>JAK3</i> , <i>RAG1</i> , and <i>RAG2</i>.

medRxiv : the preprint server for health sciences·2025
Same journal

New approaches to the management of cutaneous lupus.

Current opinion in rheumatology·2026
Same journal

"Updates in chronic nonbacterial osteomyelitis: emerging insights across the age spectrum".

Current opinion in rheumatology·2026
Same journal

Difficult-to-treat, complex-to-manage, treatment-refractory spondyloarthritis: semantics or substance?

Current opinion in rheumatology·2026
Same journal

Update on IgA nephropathy: implications for treatment in IgA vasculitis: a guide for rheumatologists.

Current opinion in rheumatology·2026
Same journal

Polyarticular juvenile idiopathic arthritis: insights from genetic studies on disease risk and pathogenesis.

Current opinion in rheumatology·2026
Same journal

Immune dysregulation in children with Down syndrome: clinical implications and emerging therapies.

Current opinion in rheumatology·2026
See all related articles

Area of Science:

  • Immunology
  • Molecular Biology
  • Genetics

Background:

  • Antibody production is vital for immune defense against extracellular pathogens.
  • Class switch recombination and somatic hypermutation are key processes shaping the antibody repertoire.
  • Primary immune deficiencies, including hyper-IgM syndromes, highlight defects in these B-cell differentiation pathways.

Purpose of the Study:

  • To identify novel genes and molecular events involved in terminal B-cell differentiation.
  • To understand the mechanisms underlying hyper-IgM syndromes.
  • To explore the links between B-cell differentiation defects, lymphoid tumorigenesis, and autoimmunity.

Main Methods:

  • Investigation of rare primary immune deficiencies (hyper-IgM syndromes).

Related Experiment Videos

  • Analysis of molecular events driving B-cell terminal differentiation.
  • Genetic studies to identify causative genes and pathways.

    • Main Results:

    • Discovery of novel genes critical for antibody class switching and somatic hypermutation.
    • Elucidation of molecular mechanisms governing terminal B-cell differentiation.
    • Identification of links between these genetic defects and disease pathogenesis.

    Conclusions:

    • Defects in genes regulating B-cell differentiation cause hyper-IgM syndromes.
    • These findings provide insights into the molecular basis of antibody diversity and immune responses.
    • Understanding these pathways may inform strategies for treating lymphoid cancers and autoimmune diseases.